{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:52:02Z","timestamp":1793350322452,"version":"4.5.0"},"reference-count":26,"publisher":"BMJ","issue":"24","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2008129"],"award-info":[{"award-number":["2008129"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,6,17]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer survivors have an increased risk of heart failure, but this is balanced by the risk of death from other causes. The results of this balance impact on the optimal time for guideline-recommended surveillance for cardiac dysfunction. This study aimed to investigate the association between cancer history and cardiac function at various times during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included participants with documented cancer history from cancer registries and matched with non-cancer controls using propensity scoring based on age, sex, diabetes and blood pressure. Cardiac function, primarily left ventricular ejection fraction (LVEF), was assessed using cardiac magnetic resonance (CMR). Multivariable binomial regression analyses were conducted to analyse the association between cancer and cardiac function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 23\u2009854 cancer survivors (aged 61.0\u00b16.8 years, 60.9% female) and an equal number of matched controls, 1051 survivors and 1538 controls underwent CMR. Survivors from breast or haematological malignancies demonstrated minor differences in LVEF (59.5\u00b16.4 vs 60.1\u00b16.4, p&lt;0.001) and global circumferential strain (\u221222.4\u00b13.5 vs \u221222.6\u00b13.5, p&lt;0.001) compared with controls. Analysis stratified by time since cancer diagnosis revealed that both LVEF (p=0.014) and global circumferential strain (p=0.045) were less likely to be impaired with increasing time from diagnosis. Cancer survivors (prevalence ratio (PR)=1.19 (95% CI 1.05 to 1.35), p=0.006), particularly breast cancer (PR=1.39 (95% CI 1.18 to 1.64), p&lt;0.001), were associated with low LVEF (\u226455%) after adjusting for age, sex, years since cancer diagnoses and blood pressure medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with people without cancer, cancer survivors have a higher risk of subclinical cardiac dysfunction. However, dysfunction is less common with increasing time since cancer diagnosis. These findings suggest prioritising cardiac monitoring early in survivorship, especially in breast cancer survivors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2025-326282","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:20:26Z","timestamp":1754414426000},"page":"1199-1206","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Surveillance of left ventricular function among cancer survivors"],"prefix":"10.1136","volume":"111","author":[{"given":"Cheng Hwee","family":"Soh","sequence":"first","affiliation":[{"name":"Imaging Research, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Marwick","sequence":"additional","affiliation":[{"name":"Imaging Research, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2025112502150599000_111.24.1199.1","first-page":"4229","volume-title":"The European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J","volume":"43","author":"Lyon","year":"2022"},{"key":"2025112502150599000_111.24.1199.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182a88099"},{"key":"2025112502150599000_111.24.1199.3","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1200\/JCO.2001.19.10.2746","article-title":"Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients","volume":"19","author":"Meinardi","year":"2001","journal-title":"J Clin Oncol"},{"key":"2025112502150599000_111.24.1199.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.12.011"},{"key":"2025112502150599000_111.24.1199.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5400"},{"key":"2025112502150599000_111.24.1199.6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ejhf.1610","article-title":"Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50\u2009years","volume":"22","author":"Jacobse","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025112502150599000_111.24.1199.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-020-00683-3","article-title":"Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update","volume":"22","author":"Kawel-Boehm","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025112502150599000_111.24.1199.8","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/ERP-20-0029","article-title":"Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management","volume":"7","author":"Kanagala","year":"2020","journal-title":"Echo Res Pract"},{"key":"2025112502150599000_111.24.1199.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025112502150599000_111.24.1199.10","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeaa297"},{"key":"2025112502150599000_111.24.1199.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-018-0471-x","article-title":"Automated cardiovascular magnetic resonance image analysis with fully convolutional networks","volume":"20","author":"Bai","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025112502150599000_111.24.1199.12","doi-asserted-by":"publisher","DOI":"10.1109\/42.796284"},{"key":"2025112502150599000_111.24.1199.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.077"},{"key":"2025112502150599000_111.24.1199.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2013.03.008"},{"key":"2025112502150599000_111.24.1199.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600346"},{"key":"2025112502150599000_111.24.1199.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"2025112502150599000_111.24.1199.17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jamaoncol.2018.7192","article-title":"Long-term Somatic Disease Risk in Adult Danish Cancer Survivors","volume":"5","author":"Kjaer","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025112502150599000_111.24.1199.18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1213\/ANE.0000000000000088","article-title":"Perioperative Assessment of Myocardial Deformation","volume":"118","author":"Duncan","year":"2014","journal-title":"Anesthesia & Analgesia"},{"key":"2025112502150599000_111.24.1199.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2015.02.007"},{"key":"2025112502150599000_111.24.1199.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.2011.01410.x"},{"key":"2025112502150599000_111.24.1199.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-06838-w","article-title":"Cardiovascular disease events within 5\u2009years after a diagnosis of breast cancer","volume":"20","author":"Mery","year":"2020","journal-title":"BMC Cancer"},{"key":"2025112502150599000_111.24.1199.22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"The Lancet"},{"key":"2025112502150599000_111.24.1199.23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji067"},{"key":"2025112502150599000_111.24.1199.24","article-title":"Applied Cardio-Oncology in Hematological Malignancies: A Narrative Review","volume":"14","author":"Mandala","year":"2024","journal-title":"Life (Basel)"},{"key":"2025112502150599000_111.24.1199.25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx246"},{"key":"2025112502150599000_111.24.1199.26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaccao.2024.04.010","article-title":"Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors","volume":"6","author":"Soh","year":"2024","journal-title":"JACC CardioOncol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2025-326282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:15:26Z","timestamp":1764065726000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2025-326282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":26,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,11,25]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/heartjnl-2025-326282"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2025-326282","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}